Precision Therapeutics raises $33 million in Series D financing

06/14/2010 | American City Business Journals

Precision Therapeutics secured $33 million in a Series D funding round, led by venture capital firm Bain Capital. Precision will use the proceeds to boost the growth of ChemoFx, a technology that helps identify a type of chemotherapy that is likely to benefit an individual cancer patient, and develop genomics-based products.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD